Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease

Journal of Clinical Periodontology

Volumn 31, Issue 8, 2004, Pages 671-679

  Garlet, Gustavo P ^a   Martins Jr , Walter ^a   Fonseca, Benedito A L ^b   Ferreira, Beatriz R ^a   Silva, João S ^a,b  

^a UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Matrix metalloproteinases; Osteoprotegerin; Periodontal disease; RANKL; Tissue inhibitors of metalloproteinases

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; MATRIX METALLOPROTEINASE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GINGIVAL BIOPSY; HEALTH STATUS; HUMAN; HUMAN TISSUE; MALE; OSTEOCLAST; PERIODONTAL DISEASE; PERIODONTITIS; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM;

ADULT; CARRIER PROTEINS; CHRONIC DISEASE; CYTOKINES; EPIDEMIOLOGIC METHODS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; OSTEOPROTEGERIN; PERIODONTAL DISEASES; POLYMERASE CHAIN REACTION; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 4143063439     PISSN: 03036979     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-051X.2004.00545.x     Document Type: Article

References (58)

1. Aiba, T., Akeno, N., Kawane, T., Okamoto, H. & Horiuchi, N. (1996) Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. European Journal of Oral Sciences 104, 562-569.
2. Alexander, M. B. & Damoulis, P. D. (1994) The role of cytokines in the pathogenesis of periodontal disease. Current Opinion Periodontology 1, 39-53.
3. Alpagot, T., Bell, C., Lundergan, W., Chambers, D. W. & Rudin, R. (2001) Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis. Journal of Clinical Periodontology 28, 353-359.
4. Baker, A. H., Edwards, D. R. & Murphy, G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. Journal of Cell Science 115, 3719-3727.
5. Baker, P. J. (2000) The role of immune responses in bone loss during periodontal disease. Microbes and Infection 2, 1181-1192.
6. Birkedal-Hansen, H. (1993) Role of matrix metalloproteinases in human periodontal diseases. Journal of Periodontology 64, 474-484.
7. Birkedal-Hansen, H., Moore, W. G., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A. & Engler, J. A. (1993) Matrix metalloproteinases: a review. Critical Reviews in Oral Biology & Medicine 4, 197-250.
8. Dahan, M., Nawrocki, B., Elkaim, R., Soell, M., Bolcato-Bellemin, A. L., Birembaut, P. & Tenenbaum, H. (2001) Expression of matrix metalloproteinases in healthy and diseased human gingiva. Journal of Clinical Periodontology 28, 128-136.
9. Dean, D. D., Martel-Pelletier, J., Pelletier, J. P., Howell, D. S. & Woessner, J. F. Jr. (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. Journal of Clinical Investigation 84, 678-685.
10. Eastcott, J. W., Yamashita, K., Taubman, M. A., Harada, Y. & Smith, D. J. (1994) Adoptive transfer of cloned T helper cells ameliorates periodontal disease in nude rats. Oral Microbiology & Immunology 9, 284-289.
11. Garlet, G. P., Martins, W. Jr., Ferreira, B. R., Milanezi, C. M. & Silva, J. S. (2003) Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. Journal of Periodontal Research 38, 210-217.
12. Genco, R. J. (1992) Host responses in periodontal diseases: current concepts. Journal of Periodontology 63, 338-355.
13. Giannelli, G., Bergamini, C., Marinosci, F., Fransvea, E., Quaranta, M., Lupo, L., Schiraldi, O. & Antonaci, S. (2002) Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. International Journal of Cancer 97, 425-431.
14. Goldbach-Mansky, R., Lee, J. M., Hoxworth, J. M., Smith, D. II,, Duray, P., Schumacher, R. H. Jr., Yarboro, C. H., Klippel, J., Kleiner, D. & El-Gabalawy, H. S. (2000) Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Research 2, 145-153.
15. Golub, L. M., McNamara, T. F., Ryan, M. E., Kohut, B., Blieden, T., Payonk, G., Sipos, T. & Baron, H. J. (2001) Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. Journal of Clinical Periodontology 28, 146-156.
16. Haerian, A., Adonogianaki, E., Mooney, J., Docherty, J. P. & Kinane, D. F. (1995) Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites. Journal of Clinical Periodontology 22, 505-509.
17. Harris, S. G., Padilla, J., Koumas, L., Ray, D. & Phipps, R. P. (2002) Prostaglandins as modulators of immunity. Trends in Immunology 23, 144-150.
18. Ingman, T., Tervahartiala, T., Ding, Y., Tschesche, H., Haerian, A., Kinane, D. F., Konttinen, Y. T. & Sorsa, T. (1996) Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. Journal of Clinical Periodontology 23, 1127-1132.
19. Katagiri, T. & Takahashi, N. (2002) Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Diseases 8, 147-159.
20. Katrib, A., Smith, M. D., Ahern, M. J., Slavotinek, J., Stafford, L., Cuello, C., Bertouch, J. V., McNeil, H. P. & Youssef, P. P. (2003) Reduced chemokine and matrix metalloproteinase expression in patients with rheumatoid arthritis achieving remission. Journal of Rheumatology 30, 10-21.
21. Kawai, T., Eisen-Lev, R., Seki, M., Eastcott, J. W., Wilson, M. E. & Taubman, M. A. (2000) Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. Journal of Immunology 164, 2102-2109.
22. Kawashima, N. & Stashenko, P. (1999) Expression of bone resorptive cytokines and regulatory cytokines in murine periapical inflammation. Archives of Oral Biology 44, 55-66.
23. Kinane, D. F. & Lappin, D. F. (2001) Clinical, pathological and immunological aspects of periodontal disease. Acta Odontologica Scandinavica 59, 154-160.
24. Kong, Y. Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., Wong, T., Campagnuolo, G., Moran, E., Bogoch, E. R., Van, G., Nguyen, L. T., Ohashi, P. S., Lacey, D. L., Fish, E., Boyle, W. J. & Penninger, J. M. (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304-309.
25. Kubota, T., Nomura, T., Takahashi, T. & Hara, K. (1996) Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Archives of Oral Biology 41, 253-262.
26. Lanchou, J., Corbel, M., Tanguy, M., Germain, N., Boichot, E., Theret, N., Clement, B., Lagente, V. & Malledant, Y. (2003) Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Critical Care Medicine 31, 536-542.
27. Lappin, D. F., Macleod, C., Kerr, A., Mitchell, T. & Kinane, D. F. (2001) Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue. Clinical Experimental Immunology 123, 294-300.
28. Liu, D., Xu, J. K., Figliomeni, L., Huang, L., Pavlos, N. J., Rogers, M., Tan, A., Price, P. & Zheng, M. H. (2003) Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. International Journal of Molecular Medicine 11, 17-21.
29. Mercado, F. B., Marshall, R. I., Klestov, A. C. & Bartold, P. M. (2001) Relationship between rheumatoid arthritis and periodontitis. Journal of Periodontology 72, 779-787.
30. Murphy, G., Docherty, A. J., Hembry, R. M. & Reynolds, J. J. (1991) Metalloproteinases and tissue damage. British Journal of Rheumatology 30, 25-31.
31. Nawrocki, B., Polette, M., Marchand, V., Monteau, M., Gillery, P., Tournier, J. M. & Birembaut, P. (1997) Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses. International Journal of Cancer 72, 556-564.
32. Nomura, T., Ishii, A., Oishi, Y., Kohma, H. & Hara, K. (1998) Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases. Oral Diseases 4, 231-240.
33. Novak, M. J., Johns, L. P., Miller, R. C. & Bradshaw, M. H. (2002) Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis. Journal of Periodontology 73, 762-769.
34. Ramamurthy, N. S., Xu, J. W., Bird, J., Baxter, A., Bhogal, R., Wills, R., Watson, B., Owen, D., Wolff, M. & Greenwald, R. A. (2002) Inhibition of alveolar bone loss by matrix metalloproteinase inhibitors in experimental periodontal disease. Journal of Periodontal Research 37, 1-7.
35. Reynolds, J. J. (1996) Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Diseases 2, 70-76.
36. Reynolds, J. J., Hembry, R. M. & Meikle, M. C. (1994) Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Advances in Dental Research 8, 312-319.
37. Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G. & Schwarz, E. M. (2003) Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. Journal of Clinical Investigation 111, 821-831.
38. Roberts, F. A., McCaffery, K. A. & Michalek, S. M. (1997) Profile of cytokine mRNA expression in chronic adult periodontitis. Journal of Dental Research 76, 1833-1839.
39. Rodan, G. A. & Martin, T. J. (2000) Therapeutic approaches to bone diseases. Science 289, 1508-1514.
40. Romas, E., Gillespie, M. T. & Martin, T. J. (2002) Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30, 340-346.
41. Ryan, M. E., Ramamurthy, S. & Golub, L. M. (1996) Matrix metalloproteinases and their inhibition in periodontal treatment. Current Opinion in Periodontology 3, 85-96.
42. Sasaki, H., Hou, L., Belani, A., Wang, C. Y., Uchiyama, T., Muller, R. & Stashenko, P. (2000) IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. Journal of Immunology 165, 3626-3630.
43. Schulze, C. J., Wang, W., Suarez-Pinzon, W. L., Sawicka, J., Sawicki, G. & Schulz, R. (2003) Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury. Circulation 107, 2487-2492.
44. Seymour, G. J. & Gemmel, E. (2001) Cytokines in periodontal disease: where to from here? Acta Odontologica Scandinavica 59, 167-173.
45. Sezer, O., Heider, U., Zavrski, I., Kuhne, C. A. & Hofbauer, L. C. (2003) RANK ligand and osteoprotegerin in myeloma bone disease. Blood 101, 2094-2098.
46. Sodek, J. & Overall, C. M. (1992) Matrix metalloproteinases in periodontal tissue remodelling. Matrix 1 (Suppl.), 352-362.
47. Soell, M., Elkaim, R. & Tenenbaum, H. (2002) Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients. Journal of Dental Research 81, 174-178.
48. Taubman, M. A. & Kawai, T. (2001) Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Critical Reviews in Oral Biology & Medicine 12, 125-135.
49. Teitelbaum, SL. (2000) Bone resorption by osteoclasts. Science 289, 1504-1508.
50. Teng, Y. T. (2002) Mixed periodontal Th1-Th2 cytokine profile in Actinobacillus actinomycetemcomitans-specific osteoprotegerin ligand (or RANK-L)- mediated alveolar bone destruction in vivo. Infection and Immunity 70, 5269-5273.
51. Teng, Y. T., Nguyen, H., Gao, X., Kong, Y. Y., Gorczynski, R. M., Singh, B., Ellen, R. P. & Penninger, J. M. (2000) Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. Journal of Clinical Investigation 106, 59-67.
52. Tokoro, Y., Matsuki, Y., Yamamoto, T., Suzuki, T. & Hara, K. (1997) Relevance of local Th2-type cytokine mRNA expression in immunocompetent infiltrates in inflamed gingival tissue to periodontal diseases. Clinical Experimental Immunology 107, 166-174.
53. Tuter, G., Kurtis, B. & Serdar, M. (2002) Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. Journal of Periodontology 73, 487-493.
54. Ukai, T., Mori, Y., Onoyama, M. & Hara, Y. (2001) Immunohistological study of interferon-g and interleukin-4-bearing cells in human periodontitis gingiva. Archives of Oral Biology 46, 901-908.
55. Van der Zee, E., Everts, V. & Beertsen, W. (1997) Cytokines modulate routes of collagen breakdown. Review with special emphasis on mechanisms of collagen degradation in the periodontium and the burst hypothesis of periodontal disease progression. Journal of Clinical Periodontology 24, 297-305.
56. Vu, T. H. & Werb, Z. (2000) Matrix metalloproteinases: effectors of development and normal physiology. Genes Development 14, 2123-2133.
57. Werb, Z. (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91, 439-442.
58. Yoshihara, Y., Nakamura, H., Obata, K., Yamada, H., Hayakawa, T., Fujikawa, K. & Okada, Y. (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Annals of the Rheumatic Diseases 59, 455-461.